查看所有供应商和价格请点击:
871701-87-0生产厂家
871701-87-0价格
化源商城直购
[1]. Ho MY, et al. Trametinib, a first-in-class oral MEK inhibitor mass balance study with limited enrollment of two male subjects with advanced cancers. Xenobiotica. 2014 Apr;44(4):352-68.